Non-melanoma skin cancer killing more people than melanoma, new study finds
Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the European Academy of Dermatology and Venerology (EADV) Congress 2023 has found
2023-10-11
(Press-News.org) (Wednesday, 11 October 2023, Berlin, Germany) Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the European Academy of Dermatology and Venerology (EADV) Congress 2023 has found.1,2
Researchers also believe that NMSC is underreported and that the true impact of this disease may be even higher than estimated.3
Professor Thierry Passeron, lead author of the study, explains, “Although NMSC is less likely to be fatal than melanoma skin cancer, its prevalence is strikingly higher. In 2020, NMSC accounted for 78% of all skin cancer cases, resulting in over 63,700 deaths. In contrast, melanoma caused an estimated 57,000 fatalities in the same year. The significantly higher incidence of NMSC has, therefore, led to a more substantial overall impact.”
Professor Passeron adds, “As alarming as these figures are, they may, in fact, be underestimated. NMSC is often underreported in cancer registries, making it challenging to understand the true burden.”
In addition to examining the overall burden of skin cancers, the researchers identified specific population groups that were more at risk of this disease, including people who work outside, organ transplant recipients and those who have the skin condition xeroderma pigmentosum (an inherited extreme sun sensitivity condition).1,4
The study, which utilised data from the World Health Organization International Agency for Research on Cancer, found a high incidence of skin cancer in fair-skinned and elderly populations from the USA, Germany, UK, France, Australia and Italy.1 However, even countries with a high proportion of dark phenotypes were not immune to the risk of death from skin cancer, as demonstrated by the registered 11,281 deaths in Africa.1
In 2020, there were nearly 1.2 million reported cases of NMSC worldwide compared with 324,635 cases of melanoma.3 The majority of skin cancer occurrences are non-melanoma, referring to a group of cancers that slowly develop in the upper layers of the skin, with common types including basal cell carcinoma and squamous cell carcinoma.2,5 In comparison with melanoma, a type of skin cancer that develops in the melanocytes (cells that produce melanin), NMSC is less likely to spread to other parts of the body and can be treated more easily.5,6
Professor Passeron comments, “We have to get the message out that not only melanoma can be fatal, but NMSC also. It's crucial to note that individuals with melanin rich skin are also at risk and are dying from skin cancer. There is a need to implement effective strategies to reduce the fatalities associated with all kinds of skin cancers.”
“Our study did not find consistent evidence to suggest that having more dermatologists per capita could reduce mortality rates. Surprisingly, countries like Australia, the UK and Canada, with fewer dermatologists, exhibited low mortality-to-incidence ratios. We therefore need to explore what strategies these countries are employing to reduce the impact of skin cancer in further depth. The involvement of other healthcare practitioners, such as GPs, in the identification and management of this disease may partly explain their success. There remains huge opportunity worldwide to elevate the role of GPs and other healthcare professionals in this process and train them to recognise suspicious lesions early.”
“In alignment with this, there is an ongoing need to develop awareness campaigns that educate the general public about the risks of sun exposure and other relevant risk factors. These campaigns should be tailored to at-risk populations, including those with fair skin, outdoor workers, the elderly and individuals who are immunosuppressed. Importantly, these efforts should also extend to populations that may not typically be considered at high risk, such as darker-skinned populations.”
Professor Passeron concludes, “Skin cancers are preventable and treatable, so we need to do more to ensure we are stopping the progression of this disease as early as possible to save lives.”
END
Note to editors:
A reference to the EADV Congress 2023 must be included in all coverage and/or articles associated with this study.
For more information or to arrange an expert interview, please contact Phoebe May at phoebe.may@emotiveagency.com or press@eadv.org.
Disclosures:
This work has been conducted by L’Oréal Dermatological Beauty Corporate and Social Responsibility team, and La Roche-Posay experts, in collaboration with Professor Thierry Passeron and with the support of FutureBridge company.
About the study author:
Professor Thierry Passeron is Professor and Chair of Dermatology in the University hospital of Nice. He also heads the laboratory INSERM U1065 team 12, C3M, dedicated to the study of molecular mechanisms involved in pigmentation and melanoma. He heads the University laser center in Nice. He is President of the Department of Clinical Research and Innovation of Nice University hospital and Vice-president of Côte d’Azur University. He has 12 international patents and more than 330 publications in scientific journals (h-index 55). He is the co-founder of Yukin therapeutics. His fields of research include pigmentary disorders (including vitiligo and melasma), melanoma, hidradenitis suppurativa, alopecia areata and lasers.
About EADV:
Founded in 1987, EADV is a non-profit organisation with a vision to form a premier European Dermatology-Venereology Society. The Academy counts over 9000 members from 120 countries, providing a valuable service for every type of dermatologist-venereologist professional. The EADV is dedicated to advancing patient care, education and research by providing a unique platform to bring people together and share ideas.
This year, the EADV Congress will take place in Berlin, Germany, and online from
11–14 October 2023.
Find out more via the EADV website: https://www.eadv.org/
References:
Salah S, et al. A comprehensive analysis of global skin cancer incidence and mortality with a focus on dermatologist density and population risk factors. Presented at the EADV Congress 2023; 11 October 2023; Berlin, Germany.
NHS. Overview: Skin cancer (non-melanoma). (Last updated January 2020). Available at: https://www.nhs.uk/conditions/non-melanoma-skin-cancer/ (Accessed: September 2023).
World Cancer Research Fund International. Skin cancer statistics. (Last updated March 2022). Available at: https://www.wcrf.org/cancer-trends/skin-cancer-statistics/ (Accessed: September 2023).
Cancer.Net. Xeroderma pigmentosum. November 2022. Available at: https://www.cancer.net/cancer-types/xeroderma-pigmentosum (Accessed: September 2023).
Premier Surgical. What’s the difference between melanoma and non-melanoma skin cancer? January 2016. Available at: https://www.premiersurgical.com/01/whats-the-difference-between-melanoma-and-non-melanoma-skin-cancer/ (Accessed: September 2023).
Mayo Clinic. Melanoma. July 2023. Available at: https://www.mayoclinic.org/diseases-conditions/melanoma/symptoms-causes/syc-20374884 (Accessed: September 2023).
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-10-10
Fat tissue, for as much as it’s been vilified, is an incredibly complex and essential bodily organ involved in energy storage and hormone production, among other functions. Yet, modern lifestyles have led to a worldwide epidemic of obesity, and a corresponding increase in related conditions like type 2 diabetes and cardiovascular disease.
Researchers are attempting to uncover the basics of how fat tissue is structured and, specifically, inflammation associated with obesity, in the hopes of unlocking the connection between the accumulation of fat and poor health outcomes.
A new study from Lindsey Muir, Ph.D., Ph.D.-candidate Cooper Stansbury, and their colleagues ...
2023-10-10
LAWRENCE — Bringing an idea from a lab to patients and consumers can be a complicated and intimidating process involving patents, governmental regulations, product development, business structuring, hiring issues and many more complex considerations.
Now, a $3 million initiative based at the University of Kansas will empower biomedical researchers in public universities and colleges across several Plains states to carry their innovations to the marketplace.
The effort involves both a private firm based at KU Innovation Park, Continuum Educational Technologies PBC, and KU researchers working under a new $3 million grant from ...
2023-10-10
New Haven, Conn. — Immune cells play a key role during pregnancy, adjusting immune system response in a way that enables the fetus to develop while also protecting the parent and fetus from outside assaults like viruses. In a new study, Yale researchers found that a particular protein found throughout the body plays a major role in this important immune system modulation, affecting placental health early in pregnancy.
The findings, they say, could lead to new treatments for reproductive conditions in the future.
The study, led by Yale School of Medicine’s Reshef Tal, was published Oct. 10 in the journal JCI Insight. A human fetus contains ...
2023-10-10
ITHACA, N.Y. -- Cornell researchers have developed a new optimization tool to estimate motion throughout an input video, which has potential applications in video editing and generative AI video creation.
The tool, called OmniMotion, is described in a paper, “Tracking Everything, Everywhere, All at Once,” presented at the International Conference on Computer Vision, Oct. 2-6 in Paris.
“There are these two dominant paradigms in motion estimation – optical flow, which is dense but short range, and feature tracking, which is sparse but long range,” said Noah ...
2023-10-10
BOSTON – When cancer screening in a patient reveals an abnormal test result, prompt follow-up is critical so that further tests can be conducted, and if needed, treatment can be initiated as soon as possible. Numerous barriers to such follow-up exist, however.
A recent clinical trial led by investigators at Massachusetts General Hospital (MGH), a founding member of Mass General Brigham (MGB), has demonstrated promising results for a multilevel intervention including an automated reminder in patients’ electronic health records (EHRs) and patient outreach efforts to improve the rates of ...
2023-10-10
Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.
The results, published this week in Nature Microbiology, showed that, when given intravenously, the only commercially available vaccine against TB successfully and safely prevents lung infection in monkeys infected with the simian, or primate, form of HIV, called SIV. This is despite the vaccine being contraindicated for people living with HIV.
“What is really exciting about this study is that, for ...
2023-10-10
The Milky Way is often depicted as a flat, spinning disk of dust, gas, and stars. But if you could zoom out and take an edge-on photo, it actually has a distinctive warp — as if you tried to twist and bend a vinyl LP.
Though scientists have long known through observational data that the Milky Way is warped and its edges are flared like a skirt, no one could explain why.
Now, Harvard astronomers at the Center for Astrophysics | Harvard and Smithsonian (CfA) have performed the first ...
2023-10-10
One produces richly detailed interpretations of Black America’s past and present, the other pathbreaking technologies that further understanding of gene expression. Today, two professors in the Faculty of Arts and Sciences were named as recipients of the John D. and Catherine T. MacArthur Foundation’s 2023 “genius grant.”
Imani Perry, the Henry A. Morss Jr. and Elisabeth W. Morss Professor of Studies of Women, Gender, and Sexuality and of African and African American Studies, is a multidisciplinary thinker recognized for her fresh insights on the resilience and beauty of Black American cultural expressions. Jason ...
2023-10-10
People who carry three gene variants that have bene inherited from Neanderthals are more sensitive to some types of pain, according to a new study co-led by UCL researchers.
The findings, published in Communications Biology, are the latest findings to show how past interbreeding with Neanderthals has influenced the genetics of modern humans.
The researchers found that people carrying three so-called Neanderthal variants in the gene SCN9A, which is implicated in sensory neurons, are more sensitive to pain from skin pricking after prior exposure to mustard oil.
Previous research ...
2023-10-10
LAWRENCE — Hurricanes, floods, heat waves and other disasters are striking the United States with increased severity and frequency, and since 2000 the Federal Disaster Mitigation Act has required states and local jurisdictions to have plans in place to reduce damages from such events. A new study from the University of Kansas has found little improvement over time to these plans, in spite of regularly required updates.
Plans to mitigate risk from natural hazards hold the potential to help states and local communities proactively steer development into safer areas and reduce exposure of existing housing, businesses, roads and other vital assets. ...
LAST 30 PRESS RELEASES:
[Press-News.org] Non-melanoma skin cancer killing more people than melanoma, new study finds
Non-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of skin cancer, a new study presented today at the European Academy of Dermatology and Venerology (EADV) Congress 2023 has found
